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Abstract 
Retinal pigment epithelial (RPE) degeneration is potentially involved in the pathogenesis of several retinal 
degenerative diseases. mTORC1 signaling is shown as a crucial regulator of many biological processes and 
disease progression. In this study, we aimed at investigating the role of mTORC1 signaling in RPE degeneration. 
Methods: Western blots were conducted to detect mTORC1 expression pattern during RPE degeneration. 
Cre-loxP system was used to generate RPE-specific mTORC1 activation mice. Fundus, immunofluorescence 
staining, transmission electron microscopy, and targeted metabolomic analysis were conducted to determine 
the effects of mTORC1 activation on RPE degeneration in vivo. Electroretinography, spectral-domain optical 
coherence tomography, and histological experiments were conducted to determine the effects of mTORC1 
activation on choroidal and retinal function in vivo.  
Results: RPE-specific activation of mTORC1 led to RPE degeneration as shown by the loss of RPE-specific 
marker, compromised cell junction integrity, and intracellular accumulation of lipid droplets. RPE degeneration 
further led to abnormal choroidal and retinal function. The inhibition of mTORC1 signaling with rapamycin 
could partially reverse RPE degeneration. Targeted metabolomics analysis further revealed that mTORC1 
activation affected the metabolism of purine, carboxylic acid, and niacin in RPE.  
Conclusion: This study revealed that abnormal activation of mTORC1 signaling leads to RPE degeneration, 
which could provide a promising target for the treatment of RPE dysfunction-related diseases. 
Key words: RPE degeneration, mTORC1, metabolism 
Introduction 
RPE is a cuboidal, polarized, and pigmented 
epithelium situated between the retinal 
photoreceptors and the choriocapillaris, which forms 
part of the blood-retinal barrier [1]. RPE absorbs light, 
supplies 60% of the glucose metabolized by the retina, 
transports ions, water and metabolic end products 
from the subretinal space to the blood, participates in 
visual cycle, phagocytizes shed photoreceptor outer 
 
Ivyspring  
International Publisher 
 Theranostics 2019, Vol. 9, Issue 4 
 
 
http://www.thno.org 
1171 
segment, and secretes a variety of growth and 
immunosuppressive factors [1, 2].  
Mutations of RPE-expressed genes lead to retinal 
degenerative diseases, illustrating the importance of 
RPE function for visual maintenance in human [3, 4]. 
RPE degeneration also plays a key role in the 
pathogenesis of age-related macular degeneration 
(AMD), which is the leading cause for irreversible 
vision loss in the elderly population [5, 6]. Thus, it is 
urgent to clarify the pathogenesis of RPE 
degeneration. Previous studies show that oxidative 
damage, senescence, and dysregulated RPE 
metabolism are involved in RPE degeneration [7-9]. 
Despite intensive basic and clinical research, the 
precise mechanism of RPE degeneration is still 
unclear. 
Mechanistic target of rapamycin complex 1 
(mTORC1) regulates several important cellular 
functions, including cell growth, proliferation, 
migration, and metabolism [10-12]. Abnormal 
mTORC1 activation has been implicated in several 
diseases, including neurodegenerative diseases and 
cancers [13]. mTORC1 dysfunction has been detected 
during RPE dedifferentiation in mice [14, 15]. 
Moreover, subcellular localization and function of 
mTOR is altered in the aged RPE [16]. Taken together, 
these studies have revealed a potential link between 
mTORC1 signaling and RPE function. In this study, 
we mainly investigated whether intervention of 
mTORC1 signaling could affect the development of 
RPE degeneration. We showed that abnormal 
mTORC1 activation in mice RPE led to RPE 
degeneration, choroidal and retinal degeneration. 
Inhibition of mTORC1 by rapamycin partially rescued 
RPE degeneration, suggesting an important role of 
mTORC1 signaling in regulating RPE function.  
Methods 
Human primary RPE cell culture 
This study was approved by the ethics 
committee of EYE & ENT Hospital of Fudan 
University. The informed consent concerning the use 
of the donated eyes for research was provided by the 
Shanghai Red Cross Eye Bank. All donors were Han 
Chinese. The primary RPE cells were isolated within 
24 h after death from adult human donor eyes. All 
procedures were conducted according to the 
standards for eye donation for research and the 
ethical principles in the Declaration of Helsinki. 
RPE cultures were performed as previously 
reported [17]. Briefly, after removing the anterior 
segment, vitreous, and retina, we rinsed the eyecups 
with sterile phosphate-buffered saline (PBS) and 
incubated with 0.25% trypsin-EDTA (Gibco, Grand 
Island, NY, USA) for 30 min at 37 °C. The dissociation 
buffer was gently removed and the eyecup was filled 
with DMEM/F12 media supplemented with 10% fetal 
bovine serum (FBS) (Gibco, Grand Island, NY, USA). 
RPE was gently scraped from the Bruch’s membrane 
by a double bevel spoon blade (3.0 mm). RPE was 
cultured in DMEM/F12 media with 10% FBS in a 5% 
CO2 humidified incubator at 37 °C. Cell medium was 
replaced every 3 days. Primary RPE was cultured 
without passing for 14 days before experiments. 
Mouse breeding and genotyping 
All mice were housed in an Association for 
Assessment and Accreditation of Laboratory Animal 
Care (AAALAC)-accredited specific-pathogen-free 
(SPF) animal facility (Model Animal Research Center, 
Nanjing University, Nanjing, Jiangsu, China) with a 
12-h light/dark cycle and had ad libitum access to 
water and standard mouse chow diet. BEST1-Cre 
transgenic mice (provided by Prof Joshua L. Dunaief 
from the University of Pennsylvania, Philadelphia, 
Pennsylvania, USA) were C57BL/6J background, and 
the Cre recombinase was controlled by the fragment 
of human BEST1 promoter (-585 to +38)[18]. Mice 
with a loxP-flanked tuberous sclerosis complex 1 
(TSC1) allele (TSC1 loxP/loxP) with a mixed B6/129 
background were a kind gift from Dr. Chun-Sun Dai 
(State Key Laboratory of Reproductive Medicine, 
Institute of Toxicology, Nanjing Medical University, 
Nanjing, Jiangsu, China) [19]. As the BEST1-Cre 
transgene is expressed in the male germline [18], we 
generated the genotype (TSC1 loxP/loxP; 
+/Tg[BEST1-Cre]) (RPE-TSC1-/-) by breeding female 
BEST1-Cre transgenic mice with male TSC1 loxP/loxP 
mice (Figure S1A-D). The RPE-TSC1-/- mice served as 
the experimental group, whereas the TSC1 loxP/loxP 
littermates served as controls. Both male and female 
mice were used in this experiment. The gender was 
randomly selected in this study. Genotyping was 
carried out by PCR analysis of the genomic DNA 
isolated from mice tails. Primer sequences were listed 
in Table S1. All experimental and animal care 
procedures were performed in accordance with the 
ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research and the guidelines 
on the ethical use of animals of Fudan University. 
Immunofluorescence 
Eyes were enucleated immediately after sacrifice 
and fixed overnight in 4% paraformaldehyde (PFA). 
Eyecups were dissected, rinsed with PBS, dehydrated 
in 30% sucrose for 2 h, and embedded in optimal 
cutting temperature compound (OCT; Tissue-Tek; 
Sakura Finetek, Torrance, CA). The frozen sections of 
eyecups were cut at 10-µm thickness using a freezing 
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microtome (Leica, Hamburg, Germany). RPE flat 
mounts were prepared as described previously [14] 
and then blocked with 5% normal goat serum 
(NGS)/0.1% Triton X-100/1×PBS at room 
temperature for 1 h. Primary antibodies were 
incubated overnight at 4 °C, followed by the 
secondary antibodies (Table S2). Nuclei were 
counterstained with 4’, 6-diamidino-2-phenylindole 
(DAPI) (1:2000, Vector laboratories, Burlingame, CA, 
USA). Images were captured with Lecia SP2 
microscope (Leica, Hamburg, Germany). 
Rapamycin administration 
Three-month-old RPE-TSC1-/- mice and 
littermate controls were injected daily with rapamycin 
(3 mg/kg) or vehicle (4% ethanol, 5% Tween 80, and 
5% polyethyleneglycol 400) (n = 15 for each group) 
intraperitoneally for 2 months until sacrifice. 
Metabolite analysis by LC/MS-MS 
Briefly, isolated RPE-choroid complexes were 
processed in 80% cold methanol via homogenization 
and metabolites were analyzed using Shimadzu LC 
Nexera X2 UHPLC coupled with a QTRAP 5500 LC 
MS/MS (AB Sciex, Framingham, MA, USA). 
Chromatographic separation was achieved using 
ACQUITY UPLC BEH Amide analytic column (2.1×50 
mm, 1.7 μm, Waters) with mobile phase A (water with 
10 mM ammonium acetate with pH 8.9) and mobile 
phase B (acetonitrile/water (95/5) with 10 mM 
ammonium acetate with pH 8.2) (All solvents were 
LC-MS Optima grade from Fisher Scientific, 
Pittsburgh, PA, USA). Chromatographic separation 
was completed in a total run time of 11min with a 
gradient as previously described [20, 21]. Multiple 
reaction monitoring was performed for 97 transitions 
listed in Table S3. MultiQuant 3.0.2 software (AB 
Sciex, Framingham, MA, USA) was used to integrate 
the extracted peaks and volcano plots were used to 
analyze the data. Different metabolites and enriched 
metabolic pathways were identified by 
MetaboAnalyst software.  
Statistical analysis 
GraphPad Prism (version 5.0; GraphPad 
Software, San Diego, CA, USA) and SPSS (v19.0, SPSS, 
Chicago, IL, USA) were used for statistical analysis. 
For normally distributed data with equal variance, the 
difference was evaluated by 2-tailed Student’s t-test 
(2‐group comparisons) or 1-way ANOVA followed by 
the post hoc Bonferroni test (multi-group 
comparisons) as appropriate. For abnormally 
distributed data and data with unequal variances, the 
difference was evaluated by a nonparametric 
Mann-Whitney U test (2‐group comparisons). Data 
were shown as mean ± standard deviation (SD). P< 
0.05 was considered as statistical significance. 
Results 
mTORC1 signaling activity is altered during 
RPE degeneration 
Age is often recognized as a risk factor for RPE 
degeneration [8]. Thus, we compared the difference of 
mTORC1 activity in primary RPE cells from young (30 
years old, 33 years old and 40 years old) and elderly 
(60 years old, 67 years old, and 88 years old) donors. 
The expression of aging makers, including p27 and 
p21, was up-regulated in the elderly group (Figure 
1A). By contrast, the expression of RPE specific 
markers, including the tyrosine-protein kinase Mer 
(MERTK), kertain18 (CK18), and lecithin retinol 
acyltransferase (LRAT), was significantly down- 
regulated in the elderly donors compared to that of 
the young donors, suggesting that RPE degeneration 
occurred in the elderly group (Figure 1B). The 70 
kDa/S6 ribosomal protein (p70s6K/S6) pathway is 
regulated by mTORC1[12]. In elderly RPE, we 
detected increased phosphorylation levels of 
p70s6KThr389 and S6Ser235/236 (Figure 1C), indicating that 
mTORC1 activity was significantly up-regulated in 
the elderly donors. Taken together, these data suggest 
that mTORC1 activity is altered during RPE 
degeneration. 
RPE-specific deletion of TSC1 leads to 
mTORC1 signaling activation in RPE 
To determine the role of mTORC1 in RPE, we 
generated a mouse model for RPE-specific mTORC1 
activation by deletion of its upstream inhibitor 
tuberous sclerosis complex 1(TSC1) [22]. We crossed 
TSC1 loxP/loxP (TSC1f/f) mice with BEST1-Cre 
transgenic mice. TSC1 was deleted at the DNA level 
as expected (Figure S1D). The BEST1-Cre transgene 
induced ocular Cre expression postnatally in RPE, 
which does not cause Cre toxicity in controls [14]. We 
did not detect any abnormity of ERG response, RPE 
ultrastucture, or fundus in BEST-1 Cre mice (Figure 
S2). No mutation of rd1 or rd8 was found in these 
mice (Figure S3). TSC1 knockout by BEST1 
Cre-mediated recombination in RPE was also 
confirmed by immunofluorescence (Figure 2A-B). 
To determine whether TSC1 deletion led to the 
hyperactivation of mTORC1, we examined the 
phosphorylated levels of S6 and p70s6K. Compared 
with the controls, the phosphorylated levels of 
p70s6KThr389and S6Ser235/236 were significantly 
up-regulated in RPE-choroid complex of RPE-TSC1-/- 
mice (Figure 2C). We also observed decreased Akt 
phosphorylation (Ser 473) in the RPE of RPE-TSC1-/- 
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mice, which is consistent with a previous report 
describing the feedback inhibition by activated 
mTORC1 [23]. To determine the specific cell types in 
which mTORC1 was activated, we performed 
immunofluorescence staining and found that 
S6Ser235/236 level was significantly up-regulated in the 
RPE of RPE-TSC1-/-mice (Figure 2D). Collectively, 
these results suggest that RPE-TSC1-/- mice exhibit 
RPE-specific activation of mTORC1 signaling. 
 
 
Figure 1. mTORC1 activity is up-regulated in the aged, degenerating human RPE. (A) p21 and p27 expression was detected in the primary RPE isolated from young 
and elderly donors by Western blots. Statistical result is shown at the right panel (n = 3, *P＜0.05, mean ± standard deviation). (B) RPE markers, including MERTK, CK18, and 
LRAT, were detected by Western blots in the primary RPE isolated from the young and elderly donors. Statistical result is on the right panel (n = 3, *P＜0.05, mean ± standard 
deviation). (C) Phosphorylation levels of S6 Ser235/236 and p70s6K Thr389 protein were detected in the primary RPE isolated from the young and elderly donors. Statistical result is 
shown at the right panel (n = 3, *P＜0.05, mean ± standard deviation). 
 
Figure 2. RPE-specific deletion of TSC1 leads to mTORC1 activation in mice RPE. (A- B) TSC1 staining of RPE flat mounts (A, Scale bar: 20 μm) and retinal sections 
(B, Scale bar: 25 μm) indicated the loss of TSC1 protein in the RPE of RPE-TSC1-/- mice. Phalloidin staining was used to outline cell boundaries. (C) Phosphorylated levels of 
AktSer473, p70s6K Thr389, and S6 Ser235/236 protein in 2-month RPE-choroid complex of RPE-TSC1-/- and control group were detected by Western blots. Statistical results are also 
shown (n = 3, *P<0.05 versus control, mean ± standard deviation). (D) Retinal sections from the 2-month RPE-TSC1-/- mouse and the age-matched control were stained for 
p-S6Ser235/236 (green) to determine the activation of mTORC1 signaling. Scale bar: 25 μm. CHO: choroid; IS: inner segment; ONL: outer nuclear layer; OS: outer segment; RPE: 
retinal pigment epithelium. 
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Figure 3. RPE-specific deletion of TSC1 leads to RPE degeneration in vivo . (A) Fundus images of RPE-TSC1-/- mice at different ages are shown. (B) Immunostaining 
showed that RPE-specific deletion of TSC1 led to decreased RPE65 expression. Scale bar: 25 μm. (C-F) Transmission electron microscopy was used to observe the region of 
RPE/Bruch’s membrane/choroidal junction in 12-month-old control mice (C), 6-month-old RPE-TSC1-/- mice (D), 7-month-old RPE-TSC1-/- mice (E), and 12-month-old 
RPE-TSC1-/- mice (F). (G) Flat mounts of posterior eye from 6-month-old control and RPE-TSC1-/- mice were stained with phalloidin and β-catenin to show RPE morphological 
changes. Arrows represent the cytoplasmic translocation of β-catenin. Scale bar: 20 μm. 
 
RPE-specific deletion of TSC1 leads to RPE 
degeneration in vivo  
To reveal the phenotype of RPE-TSC1-/- mice, we 
performed in vivo and ex vivo analysis to characterize 
the morphological and molecular changes. The 
fundus of RPE-TSC1-/- mice showed a progressive 
RPE degeneration and the appearance of white spots 
by 7 months of age (Figure 3A). The white spots might 
be macroscopic manifestation of lipid buildup [14]. 
Immunofluorescence analysis showed that the 
expression of RPE65, an important RPE marker, was 
decreased in RPE-TSC1-/- mice at 3 months of age 
(Figure 3B). Transmission electron microscopy of 
12-month-old control RPE showed the normal 
monolayer structure, melanosomes distribution, and 
polarization (Figure 3C). Ultrastructural analysis of 
RPE-TSC1-/- mice at 6 months revealed intracellular 
accumulation of lipid droplets and abnormal 
melanosomes of RPE (Figure 3D). Loss of basal 
infoldings, a key morphological indicator of RPE 
polarity, was observed in 7-month-old RPE-TSC1-/- 
mice (Figure 3E). Increased pigmentary changes and 
accumulation of unprocessed phagosomes were 
detected in 12-month-old RPE-TSC1-/- mice (Figure 
3F). Immunofluorescence analysis showed that 
TSC1-specific deletion in RPE led to the loss of regular 
cuboidal appearance and increase in heterogeneity of 
the size and shape of RPE cells (Figure 3G). β-catenin 
is a marker of RPE adherens junction [24]. β-catenin 
cytoplasmic translocation was detected in a small 
number of Cre-expressing cells (Figure 3G, arrows). 
Collectively, RPE-specific deletion of TSC1 induced 
abnormal RPE morphology, intracellular 
 Theranostics 2019, Vol. 9, Issue 4 
 
 
http://www.thno.org 
1175 
accumulation of lipid droplets, loss of RPE marker, 
and abnormal RPE junction structure, suggesting that 
mTORC1 activation leads to RPE degeneration. 
RPE-specific deletion of TSC1 leads to 
choroidal pathology  
By the examination of posterior eyecups, the 
appearance of focal choroidal atrophy was detected in 
RPE-TSC1-/-mice as early as 3 months of age and the 
atrophic area increased with age (Figure 4A, arrows). 
DIC (Digital Image Correlation) examination (Figure 
4B) and H&E staining (Figure 4C-D) of RPE-TSC1-/- 
mice confirmed the posterior eyecup findings of 
choroidal thinning and atrophy. 
RPE-specific deletion of TSC1 leads to 
progressive retinal degeneration 
Retinal degeneration is regarded as the 
consequence of RPE dysfunction [25]. We recorded 
ERGs of RPE-TSC1-/- mice and controls at 5-month 
and 12-month age. Dark-adapted RPE-TSC1-/- mice 
had lower scotopic b-wave and a-wave amplitudes 
compared with the age-matched controls. At 5-month 
age, there was approximately 30% reduction in the 
scotopic b-wave amplitudes in RPE-TSC1-/- mice 
(Figure 5A-B). At 12-month age, both the scotopic a- 
and b-wave amplitudes were diminished by about 
50% (Figure 5C-D). Spectral-domain optical 
coherence tomography examination showed that the 
outer nuclear layer (ONL) thickness was significantly 
decreased in RPE-TSC1-/-mice (Figure 5E).  
 
 
Figure 4. RPE-specific deletion of TSC1 leads to choroidal pathology. (A) The eyecups of RPE/choroid from 3- to 12-month-old RPE-TSC1-/- mice exhibited 
progressive choroidal thinning (light area; white arrows). (B) The images of DIC captured from 3-to 12-month-old RPE-TSC1-/- mice showed abnormal melanosome distribution. 
Scale bar: 100 μm. (C- D) The morphology of retina/RPE choroid and sclera of 5-month-old (C) or 10-month-old (D) RPE-TSC1-/- mice and controls are shown. Scale bar: 50 μm. 
Choroid thickness was statistically analyzed. ONH, optic nerve head (n = 3, *P＜0.05, ** P＜0.01). INL: inner nuclear layer. 
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Figure 5. RPE-specific deletion of TSC1 leads to progressive retinal degeneration. (A-D) Average intensity-response curves of scotopic a-wave (A and C) and 
b-wave (B and D) amplitudes of 5-month-old and 12-month-old RPE-TSC1-/- mice and littermate controls (n = 5, *P＜0.05, ** P＜0.01). (E) Quantification of the thickness of ONL 
from SD-OCT images of RPE-TSC1-/- mice and littermate controls at 5 months. ONH, optic nerve head (n = 5,*P<0.05, ** P<0.01 versus control). 
 
Rapamycin administration partially reverses 
RPE degeneration  
To investigate whether inhibition of mTORC1 
signaling could rescue RPE dysfunction, we 
administrated RPE-TSC1-/-mice and littermate 
controls with rapamycin (rapa), a specific inhibitor of 
mTORC1 signaling [26]. We found that rapamycin 
treatment decreased the phosphorylated level of 
S6Ser235/236 and p70s6K Thr389 in RPE-TSC1-/- mice 
(Figure 6A). Decreased S6Ser235/236 phosphorylated 
level was also detected in Cre-expressing RPE (Figure 
6B). Increased RPE65 reactivity level was detected in 
the retinal sections of rapamycin-injected RPE-TSC1-/- 
mice (Figure 6C). Moreover, RPE-TSC1-/-mice showed 
improved retinal scotopic ERG response and 
increased ONL thickness after rapamycin treatment 
(Figure 6D-F). Thus, rapamycin administration could 
partially reverse RPE degeneration. 
TSC1 deletion leads to abnormal metabolism 
in RPE 
Activation of mTORC1 signaling is correlated 
with abnormal nutrient uptake and metabolism [32]. 
We speculated that RPE degeneration in RPE-TSC1-/- 
mice may be caused by dysregulated RPE 
metabolism. We used the targeted metabolomics to 
analyze 97 metabolites which were essential for 
central carbon metabolism in the RPE samples (Table 
S3). Volcano plot (5 controls and 5 RPE-TSC1-/-mice) 
analysis revealed the substantial decrease of purine 
metabolites (AMP, GMP, and Adenosine), carboxylic 
acid (Hippurate), and the product of niacin 
metabolism (Trigonellinein) in RPE of 6-month-old 
RPE-TSC1-/- mice (Figure 7A and Table 1). These 
metabolites were assessed for the enriched metabolic 
pathways using the MetaboAnalyst software and 7 
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potentially enriched pathways were identified. Of 
them, RNA transcription, purine metabolism, and 
thiamine metabolism were ranked as the top 3 
enriched pathways (Figure 7B). 
 
 
 
Figure 6. Rapamycin administration partially reverses RPE degeneration. (A) Western blots showed decreased phosphorylated levels of p70s6KThr389 and S6Ser235/236 
in RPE-choroid complex of 5-month-old RPE-TSC1-/- mice after rapamycin injection (R: RPE-TSC1-/-). (B) Immunostaining for p-S6Ser235/236 (green) and Cre (red) showed 
decreased p-S6Ser235/236 expression after rapamycin administration. rapa, rapamycin; veh, vehicle; scale bar: 25 μm. (C) Immunofluorescence staining showed increased RPE65 
(green) after injection of rapamycin in RPE-TSC1-/- mice (right); scale bar: 25 μm. (D- E) Electroretinography revealed increased scotopic b-wave and a-wave responses in 
5-month-old RPE-TSC1-/- mice after rapamycin administration compared with vehicle-treated RPE-TSC1-/- mice (n = 5, *P＜0.05, mean ± standard deviation). (F) SD-OCT 
analysis revealed increased ONL thickness in 5-month-old RPE-TSC1-/- mice after rapamycin administration compared with vehicle-treated RPE-TSC1-/- mice (n = 5, *P＜0.05, ** 
P＜0.01, mean ± standard deviation). 
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Figure 7. TSC1 deletion leads to abnormal metabolism in RPE. (A) Important features selected by the volcano plot with fold change threshold (X) 2 and t-tests 
threshold (Y) 0.1. The red circles represent features above the threshold. Both fold changes and P values were log transformed. (B) Overview of metabolite sets enrichment. 
 
Table 1. Change of representative metabolites between 
RPE-TSC1-/- and controls 
Peaks (mz/rt) FC log2 (FC) raw.pval - log 10(p) 
AMP 0.36534 -1.4527 0.00015644 3.8057 
GMP 0.45604 -1.1328 0.0013538 2.8684 
Hippurate 0.20015 -2.2309 0.0057935 2.2371 
Adenosin 0.41343 -1.2743 0.013794 1.8603 
Trigonelline 0.49413 -1.017 0.066775 1.1754 
FC: fold change; p: P value; pval: P value. 
 
Discussion 
RPE dysfunction is a primary event in the 
several retinal degeneration diseases. In this study, 
we show that the aged human RPE exhibit increased 
activation of mTORC1 signaling. RPE-specific 
activation of mTORC1 in mice leads to RPE 
dysfunction which is characterized by the loss of RPE 
marker protein, compromised cell junction integrity, 
and intracellular accumulation of lipid droplets. 
Inhibition of mTORC1 signaling with rapamycin can 
partially reverse RPE degeneration. This study 
suggests that abnormal activation of mTORC1 leads 
to RPE degeneration. 
Mechanistic target of rapamycin (mTOR) is a 
highly conserved kinase that belongs to the 
phosphoinositide 3-kinase-related protein kinases 
(PIKK) family. mTOR participates in two distinct 
complexes, mTORC1 and mTORC2. mTORC1 
regulates energy, nutrients, stress, and growth factors; 
in response to these stimuli, it drives the growth of 
cells, organs, and whole organisms [27]. mTORC1 
plays important roles in the development of 
degenerative diseases. Various neurodegenerative 
disorders exhibit dysregulated mTOR signaling, 
which potentially could be restored by rapamycin 
[28]. Previous studies have shown that mTOR 
signaling network is involved in cell senescence [8]. 
Inhibition of mTOR confers protection against a 
growing list of age-related pathologies. In addition to 
inhibiting mTORC1, TSC1 may affect other signaling 
pathways. Loss of TSC1 or TSC2 leads to activated 
GSK3β signaling and decreased melanogenesis- 
associated transcription factor expression, which 
causes pigmentation loss via mTORC1 activation [29]. 
This is consistent with the RPE hypopigmentation in 
RPE-TSC1-/- mice. Loss of TSC1 or TSC2 in mouse 
embryonic fibroblasts leads to endoplasmic reticulum 
(ER) stress [30]. TSC1 prevents dendritic cells from 
undergoing apoptosis via repressing mTORC1 and 
reactive oxygen species (ROS) pathways 
independently [31]. ROS generation and ER stress 
have been associated with RPE degeneration [32]. 
Thus, it is not surprising that TSC1/mTORC1 
network is involved in the regulation of RPE 
degeneration. 
RPE plays an important role in maintaining the 
viability of retina [33]. RPE-specific deletion of TSC1 
results in RPE degeneration and subsequent retinal 
degeneration as shown by decreased amplitudes of 
rod-driven ERG responses in RPE-TSC1-/- mice, which 
is consistent with the clinical features of AMD 
patients [34]. In addition to electrophysiological 
changes, reduced ONL thickness is shown in 
RPE-TSC1-/- mice. Photoreceptor abnormalities are 
likely the secondary response to RPE dysfunction, 
consistent with other genetic models of RPE-specific 
dysfunction [35-37]. The thinning and atrophy of 
choroid is also shown in RPE-TSC1-/- mice. 
Consistently, focal choroidal atrophy exists in the 
older subjects with posterior pole abnormalities and 
might also be related to the typical AMD [38, 39].  
The mTORC1 pathway is an important regulator 
of metabolism [40]. Abnormal RPE metabolism plays 
important roles in the pathogenesis of RPE 
degeneration [41, 42]. The metabonomics analysis 
shows that TSC1 knockout in RPE results in decreased 
metabolites (Figure 7). Purine metabolites are 
synthesized by the pentose phosphate pathway, 
which is regulated by mTOR signaling [43]. Purines 
are the basic building blocks for RNA, DNA and ATP 
[44]. The dysfunction of ATP production in RPE could 
initiate RPE degeneration [14]. Glycine is involved in 
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both purine synthesis and hippurate formation. A 
gene in glycine metabolism has been implicated in 
retinal degeneration [45]. Trigonelline is involved in 
NAD metabolism. Mutations of genes in NAD 
metabolism, such as nicotinamide nucleotide 
adenylyltransferase1 (NMNAT1) and nicotinamide 
phosphoribosyltransferase (NAMPT), have been 
found to be associated with retinal degeneration [46, 
47]. Taken together, mTORC1 signaling activation 
leads to abnormal metabolism in RPE. Further studies 
are still required to elucidate the mechanism of 
dysregulated metabolites during RPE degeneration 
and evaluate their potential for the diagnosis, 
prognosis, and treatment of retinal degenerative 
diseases. 
This study provides important evidence for the 
role of mTORC1 signaling in RPE degeneration. We, 
thus, propose a candidacy of mTORC1 signaling as a 
potential therapeutic target for treating RPE 
dysfunction-related diseases. Current studies have 
revealed that the administration of rapamycin, an 
inhibitor of mTORC1 signaling, could partially 
reverse RPE degeneration in mice. Constituents of 
mTOR signaling pathway may provide novel 
therapeutic targets to enhance the efficacy for treating 
retinal degenerative diseases. 
Conclusions 
Taken together, this study shows that mTORC1 
signaling is activated in the elderly human RPE. 
Excessive activation of mTORC1 in mice leads to 
retinal degeneration features, including RPE 
degeneration, abnormal RPE metabolism, and 
degeneration of retina and choroid. Administration of 
rapamycin partially reverses RPE degeneration. This 
study reveals that mTORC1 activation is potentially 
involved in RPE degeneration. 
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